심장 재활 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 최종 용도별, 지역별, 부문 예측(2025-2030년)

Cardiac Rehabilitation Market Growth & Trends:

The global cardiac rehabilitation market size is expected to reach USD 3.6 billion by 2030, at a CAGR of 6.0% from 2025 to 2030 according to a new report by Grand View Research, Inc. Rising incidence of lifestyle diseases such as cardiovascular conditions, obesity, and hyperlipidemia is one of the major factors responsible for growth. Technological innovations such as tele-cardiac rehabilitation, which means services provided from a distance using information technologies and telecommunications, are also another major driver of this market.

Furthermore, increase in number of health conscious people is boosting the cardiac rehabilitation market globally. The 2016 American College of Sports Medicine (ACSM) Worldwide Survey of Fitness Trends identified two new trends in the fitness industry, namely, flexibility & mobility rollers and smart phone exercise apps. This shows that people across the globe are becoming more health conscious and are using new products and techniques for better endurance.

Another factor propelling growth is supportive reimbursement pathways such as the Million Hearts initiative and the incentive payment model adopted by the Center for Medicare and Medicaid Services (CMS).

Cardiac Rehabilitation Market Report Highlights:

• Based on product, the wearable device segment dominated the market and accounted for a share of 29.0% in 2024. Increased CVD disease and technological advancements drive the growth of the market.
• Based on end use, the rehabilitation centers segment dominated the market and accounted for a share of 48.4% in 2024. Increasing CVD cases and strategic initiatives by key players drive the market's growth.
• North America cardiac rehabilitation market held a dominant share of 44.9% in 2024 owing to improved healthcare infrastructure, technological advancements, and increasing prevalence of CVDs in the U.S. & Canada.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. End-use
  • 1.2.3. Regional scope
  • 1.2.4. Estimates and forecasts timeline.
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Cardiac Rehabilitation Market Variables, Trends, & Scope

• 3.1. Market Introduction/Lineage Outlook
• 3.2. Market Size and Growth Prospects (USD Million)
• 3.3. Market Dynamics
  • 3.3.1. Market Drivers Analysis
    • 3.3.1.1. Rising prevalence of cardiovascular diseases
    • 3.3.1.2. Technological advancements
    • 3.3.1.3. Increased government initiatives
  • 3.3.2. Market Restraints Analysis
    • 3.3.2.1. High Cost of Cardiac Rehabilitation
    • 3.3.2.2. Lack of knowledge in growing and underdeveloped nations
• 3.4. Cardiac Rehabilitation Market Analysis Tools
  • 3.4.1. Porter's Analysis
    • 3.4.1.1. Bargaining power of the suppliers
    • 3.4.1.2. Bargaining power of the buyers
    • 3.4.1.3. Threats of substitution
    • 3.4.1.4. Threats from new entrants
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Economic and Social landscape
    • 3.4.2.3. Technological landscape
    • 3.4.2.4. Environmental landscape
    • 3.4.2.5. Legal landscape

Chapter 4. Cardiac Rehabilitation Market: Product Estimates & Trend Analysis

• 4.1. Product Market Share, 2024 & 2030
• 4.2. Segment Dashboard
• 4.3. Cardiac Rehabilitation Market: Product Movement Analysis, 2024 & 2030 (USD Million)
• 4.4. Treadmill
  • 4.4.1. Treadmill Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Elliptical Trainer
  • 4.5.1. Elliptical Trainer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Stabilization Ball
  • 4.6.1. Stabilization Ball Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Rower
  • 4.7.1. Rower Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.8. Wearable Devices
  • 4.8.1. Wearable Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.9. Others
  • 4.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Cardiac Rehabilitation Market: End Use Estimates & Trend Analysis

• 5.1. End Use Market Share, 2024 & 2030
• 5.2. Segment Dashboard
• 5.3. Cardiac Rehabilitation Market: End Use Movement Analysis, 2024 & 2030 (USD Million)
• 5.4. Rehabilitation Centers
  • 5.4.1. Rehabilitation Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Hospitals & Clinics
  • 5.5.1. Hospitals & Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Homecare & Others
  • 5.6.1. Homecare & Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Cardiac Rehabilitation Market: Regional Estimates & Trend Analysis by Product, End-use, and Country

• 6.1. Regional Market Share Analysis, 2024 & 2030
• 6.2. Regional Market Dashboard
• 6.3. Global Regional Market Snapshot
• 6.4. Market Size & Forecasts Trend Analysis, 2018 to 2030:
• 6.5. North America
  • 6.5.1. North America
  • 6.5.2. U.S.
    • 6.5.2.1. Key country dynamics
    • 6.5.2.2. Regulatory framework
    • 6.5.2.3. Competitive scenario
    • 6.5.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.3. Canada
    • 6.5.3.1. Key country dynamics
    • 6.5.3.2. Regulatory framework
    • 6.5.3.3. Competitive scenario
    • 6.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5.4. Mexico
    • 6.5.4.1. Key country dynamics
    • 6.5.4.2. Regulatory framework
    • 6.5.4.3. Competitive scenario
    • 6.5.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Europe
  • 6.6.1. Europe
  • 6.6.2. UK
    • 6.6.2.1. Key country dynamics
    • 6.6.2.2. Regulatory framework
    • 6.6.2.3. Competitive scenario
    • 6.6.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.3. Germany
    • 6.6.3.1. Key country dynamics
    • 6.6.3.2. Regulatory framework
    • 6.6.3.3. Competitive scenario
    • 6.6.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.4. France
    • 6.6.4.1. Key country dynamics
    • 6.6.4.2. Regulatory framework
    • 6.6.4.3. Competitive scenario
    • 6.6.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.5. Italy
    • 6.6.5.1. Key country dynamics
    • 6.6.5.2. Regulatory framework
    • 6.6.5.3. Competitive scenario
    • 6.6.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.6. Spain
    • 6.6.6.1. Key country dynamics
    • 6.6.6.2. Regulatory framework
    • 6.6.6.3. Competitive scenario
    • 6.6.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.7. Denmark
    • 6.6.7.1. Key country dynamics
    • 6.6.7.2. Regulatory framework
    • 6.6.7.3. Competitive scenario
    • 6.6.7.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.8. Sweden
    • 6.6.8.1. Key country dynamics
    • 6.6.8.2. Regulatory framework
    • 6.6.8.3. Competitive scenario
    • 6.6.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6.9. Norway
    • 6.6.9.1. Key country dynamics
    • 6.6.9.2. Regulatory framework
    • 6.6.9.3. Competitive scenario
    • 6.6.9.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
• 6.7. Asia Pacific
  • 6.7.1. Asia Pacific
  • 6.7.2. Japan
    • 6.7.2.1. Key country dynamics
    • 6.7.2.2. Regulatory framework
    • 6.7.2.3. Competitive scenario
    • 6.7.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.3. China
    • 6.7.3.1. Key country dynamics
    • 6.7.3.2. Regulatory framework
    • 6.7.3.3. Competitive scenario
    • 6.7.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.4. India
    • 6.7.4.1. Key country dynamics
    • 6.7.4.2. Regulatory framework
    • 6.7.4.3. Competitive scenario
    • 6.7.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.5. Australia
    • 6.7.5.1. Key country dynamics
    • 6.7.5.2. Regulatory framework
    • 6.7.5.3. Competitive scenario
    • 6.7.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.6. South Korea
    • 6.7.6.1. Key country dynamics
    • 6.7.6.2. Regulatory framework
    • 6.7.6.3. Competitive scenario
    • 6.7.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.7. Thailand
    • 6.7.7.1. Key country dynamics
    • 6.7.7.2. Regulatory framework
    • 6.7.7.3. Competitive scenario
    • 6.7.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 6.8. Latin America
  • 6.8.1. Latin America
  • 6.8.2. Brazil
    • 6.8.2.1. Key country dynamics
    • 6.8.2.2. Regulatory framework
    • 6.8.2.3. Competitive scenario
    • 6.8.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8.3. Argentina
    • 6.8.3.1. Key country dynamics
    • 6.8.3.2. Regulatory framework
    • 6.8.3.3. Competitive scenario
    • 6.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 6.9. MEA
  • 6.9.1. MEA
  • 6.9.2. South Africa
    • 6.9.2.1. Key country dynamics
    • 6.9.2.2. Regulatory framework
    • 6.9.2.3. Competitive scenario
    • 6.9.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9.3. Saudi Arabia
    • 6.9.3.1. Key country dynamics
    • 6.9.3.2. Regulatory framework
    • 6.9.3.3. Competitive scenario
    • 6.9.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9.4. UAE
    • 6.9.4.1. Key country dynamics
    • 6.9.4.2. Regulatory framework
    • 6.9.4.3. Competitive scenario
    • 6.9.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9.5. Kuwait
    • 6.9.5.1. Key country dynamics
    • 6.9.5.2. Regulatory framework
    • 6.9.5.3. Competitive scenario
    • 6.9.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis by Key Market Participants
• 7.2. Company Categorization
• 7.3. Company Heat Map Analysis
• 7.4. Company Profiles
  • 7.4.1. Ball Dynamics International, LLC
    • 7.4.1.1. Participant's Overview
    • 7.4.1.2. Financial Performance
    • 7.4.1.3. Product Benchmarking
    • 7.4.1.4. Recent Developments/ Strategic Initiatives
  • 7.4.2. Core Health & Fitness, LLC
    • 7.4.2.1. Participant's Overview
    • 7.4.2.2. Financial Performance
    • 7.4.2.3. Product Benchmarking
    • 7.4.2.4. Recent Developments/ Strategic Initiatives
  • 7.4.3. Honeywell International, Inc.
    • 7.4.3.1. Participant's Overview
    • 7.4.3.2. Financial Performance
    • 7.4.3.3. Product Benchmarking
    • 7.4.3.4. Recent Developments/ Strategic Initiatives
  • 7.4.4. Omron Corporation
    • 7.4.4.1. Participant's Overview
    • 7.4.4.2. Financial Performance
    • 7.4.4.3. Product Benchmarking
    • 7.4.4.4. Recent Developments/ Strategic Initiatives
  • 7.4.5. Koninklijke Philips N.V. (BioTelemetry Inc)
    • 7.4.5.1. Participant's Overview
    • 7.4.5.2. Financial Performance
    • 7.4.5.3. Product Benchmarking
    • 7.4.5.4. Recent Developments/ Strategic Initiatives
  • 7.4.6. ICU Medical (Smiths Group)
    • 7.4.6.1. Participant's Overview
    • 7.4.6.2. Financial Performance
    • 7.4.6.3. Product Benchmarking
    • 7.4.6.4. Recent Developments/ Strategic Initiatives
  • 7.4.7. Halma plc
    • 7.4.7.1. Participant's Overview
    • 7.4.7.2. Financial Performance
    • 7.4.7.3. Product Benchmarking
    • 7.4.7.4. Recent Developments/ Strategic Initiatives
  • 7.4.8. GE Healthcare
    • 7.4.8.1. Participant's Overview
    • 7.4.8.2. Financial Performance
    • 7.4.8.3. Product Benchmarking
    • 7.4.8.4. Recent Developments/ Strategic Initiatives
  • 7.4.9. Technogym
    • 7.4.9.1. Participant's Overview
    • 7.4.9.2. Financial Performance
    • 7.4.9.3. Product Benchmarking
    • 7.4.9.4. Recent Developments/ Strategic Initiatives
  • 7.4.10. Johnson Health Tech
    • 7.4.10.1. Participant's Overview
    • 7.4.10.2. Financial Performance
    • 7.4.10.3. Product Benchmarking
    • 7.4.10.4. Recent Developments/ Strategic Initiatives